About 50 million people worldwide suffer from epilepsy, and about 30–40% of these persons
have seizures that are refractory to treatment with antiepileptic medication. 2–4 Surgical …

BACKGROUND: Neuromodulation-based treatments have become increasingly important in
epilepsy treatment. Most patients with epilepsy treated with neuromodulation do not achieve …

Epilepsy affects millions of people worldwide. Approximately one-third have
pharmacoresistant epilepsy, and of these, the majority are not candidates for epilepsy …

Traumatic Brain Injury (TBI) affects a large proportion and extensive array of individuals in
the population. While precise pathological mechanisms are lacking, the growing base of …

Rehabilitation approaches for individuals with neurologic conditions have increasingly
shifted toward promoting neuroplasticity for enhanced recovery and restoration of function …

Head-to-head comparison of treatment modalities such as VNS, DBS and RNS across
different epileptic syndromes are required to decide which treatment modality is the most …

Aims. Vagus nerve stimulation (VNS) is an established option of adjunctive treatment for
patients with drug‐resistant epilepsy, however, evidence for long‐term efficacy is still limited …

Objectives Preclinical studies have shown that surgically implanted vagus nerve stimulation
(VNS) promotes recovery of consciousness and cognitive function following experimental …

Objective This study was undertaken to evaluate the efficacy of vagus nerve stimulation
(VNS) over time, and to determine which patient groups derive the most benefit. Methods …

Vagus nerve stimulation (VNS) is a neuromodulatory therapeutic option for drug-resistant
epilepsy. In randomised controlled trials, VNS implantation has resulted in over 50 …